HIV protease in a complex with the protease inhibitor ritonavir. The structure of the protease is shown by the red, blue and yellow ribbons. The inhibitor is shown as the smaller ball-and-stick structure near the centre. Created from [http://www.rcsb.org/pdb/explore.do?structureId=1HXW PDB 1HXW Enzyme inhibitors are molecules that bind to enzymes and decrease their activity. By contrast, enzyme activators increase enzymatic activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs, herbicides and pesticides are enzyme inhibitors. Image File history File links Download high-resolution version (924x635, 65 KB) I am author, image of HIV protesase with the bound protese inhibitor ritonavir I, the creator of this work, hereby release it into the public domain. ...
Image File history File links Download high-resolution version (924x635, 65 KB) I am author, image of HIV protesase with the bound protese inhibitor ritonavir I, the creator of this work, hereby release it into the public domain. ...
Human immunodeficiency virus or HIV is a retrovirus that causes Acquired Immunodeficiency Syndrome (AIDS), a condition in which the immune system begins to fail, leading to life-threatening opportunistic infections. ...
Proteases (proteinases, peptidases, or proteolytic enzymes) are enzymes that break peptide bonds between amino acids of proteins. ...
Ritonavir is a drug from the protease inhibitor class used to treat AIDS. It is manufactured as Norvir® by Abbott Laboratories. ...
In chemistry, a molecule is an aggregate of two or more atoms in a definite arrangement held together by chemical bonds [1] [2] [3] [4] [5]. Chemical substances are not infinitely divisible into smaller fractions of the same substance: a molecule is generally considered the smallest particle of a pure...
Ribbon diagram of the enzyme TIM, surrounded by the space-filling model of the protein. ...
Enzyme activity is the catalytic effect exerted by an enzyme. ...
Enzyme assays are laboratory methods for measuring enzymatic activity. ...
A pathogen or infectious agent is a biological agent that causes disease or illness to its host. ...
It has been suggested that this article or section be merged with cell metabolism and carbohydrates. ...
This article or section does not cite its references or sources. ...
A cropduster spreading pesticide. ...
The binding of an inhibitor can stop a substrate from entering the enzyme's active site or hinder the enzyme from catalysing its reaction. Inhibitor binding may or may not be reversible. Irreversible inhibitors usually react with the enzyme and change it chemically. These inhibitors modify key amino acid residues needed for enzymatic activity. In contrast, reversible inhibitors bind non-covalently and different types of inhibition are produced depending on whether these inhibitors bind the enzyme, the enzyme-substrate complex, or both. In biochemistry, a substrate is a molecule which is acted upon by an enzyme. ...
The active site of an enzyme is the binding site where catalysis occurs. ...
In chemistry and biology, catalysis is the acceleration (increase in rate) of a chemical reaction by means of a substance, called a catalyst, that is itself not consumed by the overall reaction. ...
A reversible reaction is a chemical reaction that may proceed in both the forward and reverse directions. ...
The general structure of an α-amino acid molecule, with the amine group on the left and the carboxyl group on the right. ...
It has been suggested that this article or section be merged with ligand. ...
Many drug molecules are enzyme inhibitors so their discovery and improvement is an active area of research in biochemistry and pharmacology. A medicinal enzyme inhibitor is often judged by its specificity (its lack of binding to other proteins) and its potency (its dissociation constant, which indicates the concentration needed to inhibit the enzyme). A high specificity and potency ensure that a drug will have few side effects and thus low toxicity. Oral medication A medication is a licenced drug taken to cure or reduce symptoms of an illness or medical condition. ...
Biochemistry is the study of the chemical processes and transformations in living organisms. ...
Pharmacology (in Greek: pharmacon (ÏάÏμακον) meaning drug, and logos (λÏγοÏ) meaning science) is the study of how substances interact with living organisms to produce a change in function. ...
The specificity of a binary classification test with respect to a given class is the probability that the test correctly classifies case not belonging to that class. ...
In chemistry and biochemistry, a dissociation constant or an ionization constant is a specific type of equilibrium constant used for reversible reactions or processes. ...
An adverse drug reaction (abbreviated ADR) is a term to describe the unwanted, negative consequences sometimes associated with the use of medications. ...
The skull and crossbones is a common symbol for toxicity. ...
Enzyme inhibitors also occur naturally and are involved in the regulation of metabolism. For example, enzymes in a metabolic pathway can be inhibited by downstream products. This type of negative feedback slows flux through a pathway when the products begin to build up and is an important way to maintain homeostasis in a cell. Other cellular enzyme inhibitors are proteins that specifically bind to and inhibit an enzyme target. This can help control enzymes that may be damaging to a cell, such as proteases or nucleases; a well-characterized example is the ribonuclease inhibitor, which binds to ribonucleases in one of the tightest known protein–protein interactions.[1] Natural enzyme inhibitors can also be poisons and are used as defenses against predators or as ways of killing prey. In biochemistry, a metabolic pathway is a series of chemical reactions occurring within a cell, catalyzed by enzymes, resulting in either the formation of a metabolic product to be used or stored by the cell, or the initiation of another metabolic pathway (then called a flux generating step). ...
Negative feedback is the process of feeding back to the input a part of a systems output, so as to reverse the direction of change of the output. ...
Homeostasis is the property of an open system, especially living organisms, to regulate its internal environment to maintain a stable, constant condition, by means of multiple dynamic equilibrium adjustments, controlled by interrelated regulation mechanisms. ...
Drawing of the structure of cork as it appeared under the microscope to Robert Hook from Micrographia which is the origin of the word cell. Cells in culture, stained for keratin (red) and DNA (green). ...
A representation of the 3D structure of myoglobin, showing coloured alpha helices. ...
Proteases (proteinases, peptidases, or proteolytic enzymes) are enzymes that break peptide bonds between amino acids of proteins. ...
A nuclease is an enzyme capable of cleaving the phosphodiester bonds between the nucleotide subunits of nucleic acids. ...
Top view of porcine ribonuclease inhibitor (PDB accesion code 2BNH), showing its horseshoe shape. ...
Ribonuclease (RNase) is an enzyme that catalyzes the breakdown of RNA into smaller components. ...
Reversible inhibitors
Types of reversible inhibitor Reversible inhibitors bind to enzymes with non-covalent interactions such as hydrogen bonds, hydrophobic interactions and ionic bonds. Multiple weak bonds between the inhibitor and the active site combine to produce strong and specific binding. In contrast to substrates and irreversible inhibitors, reversible inhibitors generally do not undergo chemical reactions when bound to the enzyme and can be easily removed by dilution or dialysis. Snapshot from a simulation of liquid water. ...
Hydrophobe (from the Greek (hydros) water and (phobos) fear) in chemistry refers to the physical property of a molecule that is repelled by water. ...
Electron configurations of lithium and fluorine. ...
In biochemistry, a substrate is a molecule which is acted upon by an enzyme. ...
Competitive inhibition: substrate (S) and inhibitor (I) compete for the active site. There are three kinds of reversible enzyme inhibitors. They are classified according to the effect of varying the concentration of the enzyme's substrate on the inhibitor.[2] Image File history File links Competitive_inhibitor_diagram. ...
Image File history File links Competitive_inhibitor_diagram. ...
Look up substrate in Wiktionary, the free dictionary. ...
- In competitive inhibition, the substrate and inhibitor cannot bind to the enzyme at the same time, as shown in the figure on the left. This usually results from the inhibitor having an affinity for the active site of an enzyme where the substrate also binds; the substrate and inhibitor compete for access to the enzyme's active site. This type of inhibition can be overcome by sufficiently high concentrations of substrate, i.e., by out-competing the inhibitor. Competitive inhibitors are often similar in structure to the real substrate (see examples below).
- In mixed inhibition, the inhibitor can bind to the enzyme at the same time as the enzyme's substrate. However, the binding of the inhibitor affects the binding of the substrate, and vice versa. This type of inhibition can be reduced, but not overcome by increasing concentrations of substrate. Although it is possible for mixed-type inhibitors to bind in the active site, this type of inhibition generally results from an allosteric effect where the inhibitor binds to a different site on an enzyme. Inhibitor binding to this allosteric site changes the conformation (i.e., tertiary structure or three-dimensional shape) of the enzyme so that the affinity of the substrate for the active site is reduced.
- Non-competitive inhibition is a form of mixed inhibition where the binding of the inhibitor to the enzyme reduces its activity but does not affect the binding of substrate. As a result, the extent of inhibition depends only on the concentration of the inhibitor.
In Chemistry:A chemical inhibitor is any substance which will prevent any two other substances from reacting due to its presence, often by reacting with one or the other first. ...
The active site of an enzyme is the binding site where catalysis occurs. ...
Mixed inhibition refers to a combination of two different types of reversible enzyme inhibition--competitive inhibition and uncompetitive inhibition. ...
In biochemistry, an enzyme or other protein is allosteric if its activity or efficiency changes in response to the binding of an effector molecule at a so-called allosteric site. ...
In biochemistry, an enzyme or other protein is allosteric if its activity or efficiency changes in response to the binding of an effector molecule at a so-called allosteric site. ...
Conformation generally means structural arrangement. ...
In biochemistry, the tertiary structure of a protein is its overall shape. ...
Non-competitive inhibition is a type of inhibition that reduces the maximum rate of a chemical reaction (Vmax) without changing the apparent binding affinity of the enzyme for the substrate (Km). ...
Enzyme activity is the catalytic effect exerted by an enzyme. ...
Quantitative description of reversible inhibition Reversible inhibition can be described quantitatively in terms of the inhibitor's binding to the enzyme and to the enzyme–substrate complex, and its effects on the kinetic constants of the enzyme. In the classic Michaelis–Menten scheme below, an enzyme (E) binds to its substrate (S) to form the enzyme–substrate complex ES. Upon catalysis, this complex breaks down to release product P and free enzyme. The inhibitor (I) can bind to either E or ES with the dissociation constants Ki or Ki', respectively. In chemistry and biochemistry, a dissociation constant or an ionization constant is a specific type of equilibrium constant used for reversible reactions or processes. ...
It has been suggested that this article or section be merged with Enzyme. ...
Michaelis-Menten kinetics describes the kinetics of many enzymes. ...
In chemistry and biochemistry, a dissociation constant or an ionization constant is a specific type of equilibrium constant used for reversible reactions or processes. ...
- Competitive inhibitors can bind to E, but not to ES. Competitive inhibition increases Km (i.e., the inhibitor interferes with substrate binding), but does not affect Vmax (the inhibitor does not hamper catalysis in ES because it cannot bind to ES).
- Non-competitive inhibitors have identical affinities for E and ES (Ki = Ki'). Non-competitive inhibition does not change Km (i.e., it does not affect substrate binding) but decreases Vmax (i.e., inhibitor binding hampers catalysis).
- Mixed-type inhibitors bind to both E and ES, but their affinities for these two forms of the enzyme are different (Ki ≠ Ki'). Thus, mixed-type inhibitors interfere with substrate binding (increase Km) and hamper catalysis in the ES complex (decrease Vmax).
|
Kinetic scheme for reversible enzyme inhibitors. | When an enzyme has multiple substrates, inhibitors can show different types of inhibition depending on which substrate is considered. This results from the active site containing two different binding sites within the active site, one for each substrate. For example, an inhibitor might compete with substrate A for the first binding site, but be a non-competitive inhibitor with respect to substrate B in the second binding site.[3] Image File history File links Reversible_inhibition. ...
Image File history File links Reversible_inhibition. ...
Measuring the dissociation constants of a reversible inhibitor
Lineweaver–Burk diagrams of different types of reversible enzyme inhibitors. The arrow shows the effect of increasing concentrations of inhibitor. As noted above, an enzyme inhibitor is characterized by its two dissociation constants, Ki and Ki', to the enzyme and to the enzyme-substrate complex, respectively. The enzyme-inhibitor constant Ki can be measured directly by various methods; one extremely accurate method is isothermal titration calorimetry, in which the inhibitor is titrated into a solution of enzyme and the heat released or absorbed is measured.[4] However, the other dissociation constant Ki' is difficult to measure directly, since the enzyme-substrate complex is short-lived and undergoing a chemical reaction to form the product. Hence, Ki' is usually measured indirectly, by observing the enzyme activity under various substrate and inhibitor concentrations, and fitting the data[5] to a modified Michaelis–Menten equation Image File history File links Download high-resolution version (707x1650, 36 KB) I am author. ...
Image File history File links Download high-resolution version (707x1650, 36 KB) I am author. ...
In chemistry and biochemistry, a dissociation constant or an ionization constant is a specific type of equilibrium constant used for reversible reactions or processes. ...
Isothermal Titration Calorimetry (ITC) is a biophysical technique used to determine the thermodynamic parameters of (biochemical) interactions. ...
Enzyme activity is the catalytic effect exerted by an enzyme. ...
dataset with approximating polynomials Nonlinear regression in statistics is the problem of fitting a model to multidimensional x,y data, where f is a nonlinear function of x with parameters θ. In general, there is no algebraic expression for the best-fitting parameters, as there is in linear regression. ...
It has been suggested that this article or section be merged with Enzyme. ...
![V = frac{V_{max}[S]}{alpha K_{m} + alpha^{prime}[S]} = frac{(1/alpha^{prime})V_{max}[S]}{(alpha/alpha^{prime}) K_{m} + [S]}](http://upload.wikimedia.org/math/0/5/6/0561ea39d79a20421e46a45ccc345d61.png) where the modifying factors α and α' are defined by the inhibitor concentration and its two dissociation constants ![alpha = 1 + frac{[I]}{K_{i}}](http://upload.wikimedia.org/math/2/8/0/280e85eac3f83f2370a658fe52217471.png) ![alpha^{prime} = 1 + frac{[I]}{K_{i}^{prime}}](http://upload.wikimedia.org/math/8/5/7/857b64382bd94382e988210bb7a6d772.png) Thus, in the presence of the inhibitor, the enzyme's effective Km and Vmax become (α/α')Km and (1/α')Vmax, respectively. However, the modified Michaelis-Menten equation assumes that binding of the inhibitor to the enzyme has reached equilibrium, which may be a very slow process for inhibitors with sub-nanomolar dissociation constants. In these cases, it is usually more practical to treat the tight-binding inhibitor as an irreversible inhibitor (see below); however, it can still be possible to estimate Ki' kinetically if Ki is measured independently. The effects of different types of reversible enzyme inhibitors on enzymatic activity can be visualized using graphical representations of the Michaelis–Menten equation, such as Lineweaver–Burk and Eadie-Hofstee plots. For example, in the Lineweaver-Burk plots at the right, the competitive inhibition lines intersect on the y-axis, illustrating that such inhibitors do not affect Vmax. Similarly, the non-competitive inhibition lines intersect on the x-axis, showing these inhibitors do not affect Km. However, it can be difficult to estimate Ki and Ki' accurately from such plots[6], so in research these constants are estimated using more reliable nonlinear regression methods, as described above. It has been suggested that this article or section be merged with Enzyme. ...
In biochemistry, the Lineweaver-Burk plot (or double reciprocal plot) is a graphical representation of the Lineweaver-Burk equation of enzyme kinetics, described by Hans Lineweaver and Dean Burk in 1934. ...
In biochemistry, an Eadie-Hofstee diagram (also Woolf-Eadie-Augustinsson-Hofstee or Eadie-Augustinsson plot) is a graphical representation of enzyme kinetics in which reaction velocity is plotted as a function or the velocity vs. ...
dataset with approximating polynomials Nonlinear regression in statistics is the problem of fitting a model to multidimensional x,y data, where f is a nonlinear function of x with parameters θ. In general, there is no algebraic expression for the best-fitting parameters, as there is in linear regression. ...
Special cases - The mechanism of partially competitive inhibition is similar to that of non-competitive, except that the EIS complex has catalytic activity, which may be lower or even higher (partially competitive activation) than that of the enzyme–substrate (ES) complex. This inhibition typically displays a lower Vmax, but an unaffected Km value.[7]
- Uncompetitive inhibition occurs when the inhibitor binds only to the enzyme–substrate complex, not to the free enzyme; the EIS complex is catalytically inactive. This mode of inhibition is rare and causes a decrease in both Vmax and the Km value.[7]
- Substrate and product inhibition is where either the substrate or product of an enzyme reaction inhibit the enzyme's activity. This inhibition may follow the competitive, uncompetitive or mixed patterns. In substrate inhibition there is a progressive decrease in activity at high substrate concentrations. This may indicate the existence of two substrate-binding sites in the enzyme. At low substrate, the high-affinity site is occupied and normal kinetics are followed. However, at higher concentrations, the second inhibitory site becomes occupied, inhibiting the enzyme.[8] Product inhibition is often a regulatory feature in metabolism and can be a form of negative feedback.
- Slow-tight inhibition occurs when the initial enzyme–inhibitor complex EI undergoes isomerisation to a second more tightly held complex, EI*, but the overall inhibition process is reversible. This manifests itself as slowly increasing enzyme inhibition. Under these conditions, traditional Michaelis–Menten kinetics give a false value for Ki, which is time–dependent. The true value of Ki can be obtained through more complex analysis of the on (kon) and off (koff) rate constants for inhibitor association. See irreversible inhibition for more information.
Uncompetitive inhibition takes place when an enzyme inhibitor binds only to the complex formed between the enzyme and the substrate (the E-S complex). ...
It has been suggested that this article or section be merged with Enzyme. ...
It has been suggested that this article or section be merged with cell metabolism and carbohydrates. ...
Negative feedback is the process of feeding back to the input a part of a systems output, so as to reverse the direction of change of the output. ...
Examples of reversible inhibitors As enzymes have evolved to bind their substrates tightly, and most reversible inhibitors bind in the active site of enzymes, it is unsurprising that some of these inhibitors are strikingly similar in structure to the substrates of their targets. An example of these substrate mimics are the protease inhibitors, a very successful class of antiretroviral drugs used to treat HIV.[9] The structure of ritonavir, a protease inhibitor based on a peptide and containing three peptide bonds, is shown on the right. As this drug resembles the protein that is the substrate of the HIV protease, it competes with this substrate in the enzyme's active site. Enzyme inhibitors are often designed to mimic the transition state or intermediate of an enzyme-catalyzed reaction. This ensures that the inhibitor exploits the transition state stabilizing effect of the enzyme, resulting in a better binding affinity (lower Ki) than substrate-based designs. An example of such a transition state inhibitor is the antiviral drug oseltamivir; this drug mimics the planar nature of the ring oxonium ion in the reaction of the viral enzyme neuraminidase. Image File history File links Ritonavir. ...
Image File history File links Ritonavir. ...
Ritonavir is a drug from the protease inhibitor class used to treat AIDS. It is manufactured as Norvir® by Abbott Laboratories. ...
Protease inhibitors are a class of medication used to treat or prevent viral infections. ...
Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV. Different classes of antiretroviral drugs act at different stages of the HIV life cycle. ...
Human immunodeficiency virus or HIV is a retrovirus that causes Acquired Immunodeficiency Syndrome (AIDS), a condition in which the immune system begins to fail, leading to life-threatening opportunistic infections. ...
Ritonavir is a drug from the protease inhibitor class used to treat AIDS. It is manufactured as Norvir® by Abbott Laboratories. ...
A peptide bond is a chemical bond formed between two molecules when the carboxyl group of one molecule reacts with the amino group of the other molecule, releasing a molecule of water (H2O). ...
The transition state of a chemical reaction is a particular configuration along the reaction coordinate. ...
Oseltamivir (INN) (IPA: ) is an antiviral drug used in the treatment and prophylaxis of both Influenzavirus A and Influenzavirus B. Like zanamivir, oseltamivir is a neuraminidase inhibitor. ...
Neuraminidase ribbon diagram Neuraminidase is an antigenic glycoprotein enzyme (EC 3. ...
However, not all inhibitors are based on the structures of substrates. For example, the structure of another HIV protease inhibitor tipranavir is shown on the left. This molecule is not based on a peptide and has no obvious structural similarity to a protein substrate. These non-peptide inhibitors can be more stable than inhibitors containing peptide bonds, because they will not be substrates for peptidases and are less likely to be degraded in the cell. Image File history File links Tipranavir_structure. ...
Image File history File links Tipranavir_structure. ...
Tipranavir is a new protease inhibitor (PI) that was approved by the FDA in June 2005. ...
Tipranavir is a new protease inhibitor (PI) that was approved by the FDA in June 2005. ...
Peptidases (proteases [pronounced pro-tea-aces] and proteolytic enzymes are also commonly used) are enzymes which break peptide bonds of proteins. ...
In drug design it is important to consider the concentrations of substrates to which the target enzymes are exposed. For example, some protein kinase inhibitors have chemical structures that are similar to adenosine triphosphate, one of the substrates of these enzymes. However, drugs that are simple competitive inhibitors will have to compete with the high concentrations of ATP in the cell. Protein kinases can also be inhibited by competition at the binding sites where the kinases interact with their substrate proteins, and most proteins are present inside cells at concentrations much lower than the concentration of ATP. As a consequence, if two protein kinase inhibitors both bind in the active site with similar affinity, but only one has to compete with ATP, then the competitive inhibitor at the protein-binding site will inhibit the enzyme more effectively.[10] A protein kinase is an enzyme that modifies other proteins by chemically adding phosphate groups to them (phosphorylation). ...
Adenosine 5-triphosphate (ATP), discovered in 1929 by Karl Lohmann,[1] is a multifunctional nucleotide primarily known in biochemistry as the molecular currency of intracellular energy transfer. ...
Irreversible inhibitors
Reaction of the irreversible inhibitor diisopropylfluorophosphate (DFP) with a serine protease. Image File history File links DIF_reaction. ...
Image File history File links DIF_reaction. ...
Types of irreversible inhibition Irreversible inhibitors usually covalently modify an enzyme and inhibition cannot therefore be reversed. Irreversible inhibitors often contain reactive functional groups such as nitrogen mustards, aldehydes, haloalkanes or alkenes. These electrophilic groups react with amino acid side chains to form covalent adducts. The residues modified are those with side chains containing nucleophiles such as hydroxyl or sulfhydryl groups, these include the amino acids serine (as in DFP, right), cysteine, threonine or tyrosine.[11] Covalent bonding is a form of chemical bonding characterized by the sharing of one or more pairs of electrons between atoms, in order to produce a mutual attraction, which holds the resultant molecule together. ...
The nitrogen mustards are cytotoxic chemotherapy agents similar to mustard gas. ...
An aldehyde. ...
The haloalkane (also known as halogenoalkanes) are a group of chemical compounds, consisting of alkanes, such as methane or ethane, with one or more halogens linked, such as chlorine or fluorine, making them a type of organic halide. ...
The chemical structure of ethylene, the simplest alkene. ...
In chemistry, an electrophile (literally electron-lover) is a reagent attracted to electrons that participates in a chemical reaction by accepting an electron pair in order to bond to a nucleophile. ...
In chemistry, a nucleophile (literally nucleus lover) is a reagent which is attracted to centres of positive charge. ...
// Hydroxyl group The term hydroxyl group is used to describe the functional group -OH when it is a substituent in an organic compound. ...
In organic chemistry, a thiol is a compound that contains the functional group composed of a sulfur atom and a hydrogen atom (-SH). ...
Serine is one of the 20 natural amino acids. ...
Cysteine is a naturally occurring amino acid which has a thiol group and is found in most proteins, though only in small quantities. ...
Threonine is one of the 20 natural amino acids. ...
Tyrosine (from the Greek tyros, meaning cheese, as it was first discovered in cheese), 4-hydroxyphenylalanine, or 2-amino-3(4-hydroxyphenyl)-propanoic acid, is one of the 20 amino acids that are used by cells to synthesize proteins. ...
Irreversible inhibition is different from irreversible enzyme inactivation. Irreversible inhibitors are generally specific for one class of enzyme and do not inactivate all proteins; they do not function by destroying protein structure but by specifically altering the active site of their target. For example, extremes of pH or temperature usually cause denaturation of all protein structure, but this is a non-specific effect. Similarly, some non-specific chemical treatments destroy protein structure: for example, heating in concentrated hydrochloric acid will hydrolyze the peptide bonds holding proteins together, releasing free amino acids.[12] Proteins are amino acid chains, made up from 20 different L-α-amino acids, also referred to as residues, that fold into unique three-dimensional protein structures. ...
Denaturation is a structural change in biomolecules such as nucleic acids and proteins, usually caused by heat, acids, bases, detergents, or certain chemicals such as urea. ...
Proteins are amino acid chains, made up from 20 different L-α-amino acids, also referred to as residues, that fold into unique three-dimensional protein structures. ...
The chemical compound hydrochloric acid is the aqueous (water-based) solution of hydrogen chloride (HCl). ...
A peptide bond is a chemical bond formed between two molecules when the carboxyl group of one molecule reacts with the amino group of the other molecule, releasing a molecule of water (H2O). ...
Analysis of irreversible inhibition
Kinetic scheme for irreversible inhibitors. As shown in the figure to the left, irreversible inhibitors form a reversible non-covalent complex with the enzyme (EI or ESI) and this then reacts to produce the covalently modified "dead-end complex" EI*. The rate at which EI* is formed is called the inactivation rate or kinact. Since formation of EI may compete with ES, binding of irreversible inhibitors can be prevented by competition either with substrate or with a second, reversible inhibitor. This protection effect is good evidence of a specific reaction of the irreversible inhibitor with the active site. Image File history File links Irreversible_inactivation2. ...
Image File history File links Irreversible_inactivation2. ...
The binding and inactivation steps of this reaction are investigated by incubating the enzyme with inhibitor and assaying the amount of activity remaining over time. The activity will be decrease in a time-dependent manner, usually following exponential decay. Fitting these data to a rate equation gives the rate of inactivation at this concentration of inhibitor. This is done at several different concentrations of inhibitor. If an reversible EI complex is involved the inactivation rate will be saturable and fitting this curve will give kinact and Ki[13] A quantity is said to be subject to exponential decay if it decreases at a rate proportional to its value. ...
For a chemical reaction, the rate law or rate equation is an equation which links the reaction rate with concentrations or pressures of reactants. ...
Another method that is widely used in these analysis is mass spectrometry. Here, accurate measurement of the mass of the unmodified native enzyme and the inactivated enzyme gives the increase in mass caused by reaction with the inhibitor and shows the stoichiometry of the reaction. This is usually done using a MALDI-TOF mass spectrometer. In a complementary technique, peptide mass fingerprinting involves digestion of the native and modified protein with a protease such as trypsin. This will produce a set of peptides that can be analyzed using a mass spectrometer. The peptide that changes in mass after reaction with the inhibitor will be the one that contains the site of modification. Basic schematic of a mass spectrometer Mass spectrometry (also known as mass spectroscopy (deprecated)[1] or in common speech mass-spec) is an analytical technique used to measure the mass-to-charge ratio of ions. ...
Matrix-Assisted Laser Desorption/Ionization (MALDI) is a soft ionization technique used in mass spectrometry, allowing, among others, to ionise biomolecules (biopolymers like proteins, peptides and sugarchains) which tend to be more fragile and quickly lose structure when ionised by more conventional ionisation methods. ...
Peptide mass fingerprinting (PMF) is an analytical technique for protein identification that was developed by John Yates and colleagues (3). ...
Proteases (proteinases, peptidases, or proteolytic enzymes) are enzymes that break peptide bonds between amino acids of proteins. ...
Trypsin (EC 3. ...
Peptides are the family of molecules formed from the linking, in a defined order, of various amino acids. ...
Chemical mechanism for irreversible inhibition of ornithine decarboxylase by DFMO. Pyridoxal 5'-phosphate (Py) and enzyme (E) are not shown. Adapted from [14] Image File history File links Download high-resolution version (980x400, 12 KB) I am author I, the creator of this work, hereby release it into the public domain. ...
Image File history File links Download high-resolution version (980x400, 12 KB) I am author I, the creator of this work, hereby release it into the public domain. ...
Special cases Not all irreversible inhibitors form covalent adducts with their enzyme targets. Some reversible inhibitors bind so tightly to their target enzyme that they are essentially irreversible. These tight-binding inhibitors may show kinetics similar to covalent irreversible inhibitors. In these cases, some of these inhibitors rapidly bind to the enzyme in a low-affinity EI complex and this then undergoes a slower rearrangement to a very tightly bound EI* complex (see figure above). This kinetic behavior is called slow-binding.[15] This slow rearrangement after binding often involves a conformational change as the enzyme "clamps down" around the inhibitor molecule. Examples of slow-binding inhibitors include some important drugs, such methotrexate,[16] allopurinol,[17] and the activated form of acyclovir.[18] In molecular biology, a protein may change its shape in order to undertake a new function; each possible shape is called a conformation, and a transition between them is called a conformational change. ...
Methotrexate (rINN) (IPA: ), abbreviated MTX and formerly known as amethopterin, is an antimetabolite drug used in treatment of cancer and autoimmune diseases. ...
Allopurinol is a white, powdery drug used to treat gout. ...
Aciclovir (INN) or aciclovir (USAN), marketed as Zovirax®, is one of the main antiviral drugs. ...
Examples of irreversible inhibitors
Trypanothione reductase with the lower molecule of an inhibitor bound irreversibly and the upper one reversibly. Created from PDB 1GXF. Diisopropylfluorophosphate (DFP) is shown as an example of an irreversible protease inhibitor in the figure above right. The enzyme hydrolyses the phosphorus–fluorine bond, but the phosphate residue remains bound to the serine in the active site, deactivating it. [19] Similarly, DFP also reacts with the active site of acetylcholine esterase in the synapses of neurons, and consequently is a potent neurotoxin, with a lethal dose of less than 100 mg.[20] Image File history File links Download high-resolution version (1007x733, 159 KB) I am author I, the creator of this work, hereby release it into the public domain. ...
Image File history File links Download high-resolution version (1007x733, 159 KB) I am author I, the creator of this work, hereby release it into the public domain. ...
Trypanothione is a unusual form of glutathione that is found in parasitic protozoa such as leishmania and trypanosomes (1). ...
Diisopropylfluorophosphate Diisopropylfluorophosphate (DFP, diisopropyl fluorophosphate) is an organophosphate insecticide. ...
Three amino acid residues found inside the active site of certain proteases. ...
In biochemistry, cholinesterase is a term which refers to one of the two enzymes: Acetylcholinesterase (EC 3. ...
Synapses allow nerve cells to communicate with one another through axons and dendrites, converting electrical signals into chemical ones. ...
Suicide inhibition is a unusual type of irreversible inhibition where the enzyme converts the inhibitor into a reactive form in its active site. An example is the inhibitor of polyamine biosynthesis, α-difluoromethylornithine or DFMO, which is an analogue of the amino acid ornithine, and is used to treat African trypanosomiasis (sleeping sickness). Ornithine decarboxylase can catalyse the decarboxylation of DFMO instead of ornithine, as shown above. However, this decarboxylation reaction is followed by the elimination of a fluorine atom, which converts this catalytic intermediate into a conjugated imine, a highly electrophilic species. This reactive form of DFMO then reacts with either a cysteine or lysine residue in the active site to irreversibly inactivate the enzyme.[14] Suicide inhibition, also known as suicide inactivation and mechanism-based inactivation, is a form of irreversible enzyme inhibition that occurs when an enzyme binds a substrate analogue and forms a complex with it during the normal catalysis reaction. ...
The polyamines are organic compounds, that have two or more primary amino groups, such as putrescine, spermidine, and spermine, that are growth factors in both eucaryotic and procaryotic cells. ...
Eflornithine (α-difluoromethylornithine or DFMO) is a drug manufactured by Aventis which has various uses. ...
Ornithine is an amino acid, whose structure is: NH2-CH2-CH2-CH2-CHNH2-COOH Ornithine is one of the products of the action of the enzyme arginase on L-arginine, creating urea. ...
The enzyme ornithine decarboxylase (PDB 7odc, EC 4. ...
An imine is a functional group or chemical compound containing a carbon-nitrogen double bond. ...
Since irreversible inhibition often involves the initial formation of a non-covalent EI complex, it is sometimes possible for an inhibitor to bind to an enzyme in more than one way. For example, in the figure showing trypanothione reductase from the human protozoan parasite Trypanosoma cruzi, two molecules of an inhibitor called quinacrine mustard are bound in its active site. The top molecule is bound reversibly, but the lower one is bound covalently as it has reacted with an amino acid residue through its nitrogen mustard group.[21] Trypanothione is a unusual form of glutathione that is found in parasitic protozoa such as leishmania and trypanosomes (1). ...
Chagas disease (also called American trypanosomiasis) is a Mammalian disease occurring only in the Americas. ...
The nitrogen mustards are cytotoxic chemotherapy agents similar to mustard gas. ...
Discovery and design of inhibitors
Robots used for the high-throughput screening of chemical libraries to discover new enzyme inhibitors. New drugs are the products of a long drug development process, the first step of which is often the discovery of a new enzyme inhibitor. In the past the only way to discover these new inhibitors was by trial and error: screening huge libraries of compounds against a target enzyme and hoping that some useful leads would emerge. This brute force approach is still successful and has even been extended by combinatorial chemistry approaches that quickly produce large numbers of novel compounds and high-throughput screening technology to rapidly screen these huge chemical libraries for useful inhibitors. Image File history File links Screening_robotics_for_HTS.jpgâ Author is Francis S. Collins, NIH File history Legend: (cur) = this is the current file, (del) = delete this old version, (rev) = revert to this old version. ...
Image File history File links Screening_robotics_for_HTS.jpgâ Author is Francis S. Collins, NIH File history Legend: (cur) = this is the current file, (del) = delete this old version, (rev) = revert to this old version. ...
It has been suggested that this article or section be merged into Pharmacology. ...
Combinatorial chemistry involves the rapid synthesis and/or the computer simulation of a large number of different but structurally related molecules. ...
It has been suggested that Virtual_high_throughput_screening be merged into this article or section. ...
More recently, an alternative approach has been applied: rational drug design uses the three-dimensional structure of an enzyme's active site to predict which molecules might be inhibitors. These predictions are then tested and one of these tested compounds may be a novel inhibitor. This new inhibitor is then used to try to obtain a structure of the enzyme in an inhibitor/enzyme complex to show how the molecule is binding to the active site. This structure is then inspected and changes made to the inhibitor to try to optimise binding. This test and improve cycle is then repeated until a sufficiently potent inhibitor is produced. Typically, this process aims to produce an inhibitor with a dissociation constant of <10-9 M.[22] Drug design is the approach of finding drugs by design, based on what the drug is targeting. ...
Proteins are amino acid chains, made up from 20 different L-α-amino acids, also referred to as residues, that fold into unique three-dimensional protein structures. ...
Molar may refer to: Molar (tooth), the fourth kind of tooth in mammals. ...
Uses of inhibitors Enzyme inhibitors are found in nature and are also designed and produced as part of pharmacology and biochemistry. Natural enzyme inhibitors are often poisons that have evolved to defend a plant or animal against predators. These natural toxins include some of the most poisonous compounds known today. Artificial inhibitors are often used as drugs, but can also be insecticides such as malathion, herbicides such as glyphosate or disinfectants such as triclosan. Pharmacology (in Greek: pharmacon (ÏάÏμακον) meaning drug, and logos (λÏγοÏ) meaning science) is the study of how substances interact with living organisms to produce a change in function. ...
Biochemistry is the study of the chemical processes and transformations in living organisms. ...
This article is about the dangerous substance. ...
Insecticide application by crop spraying An insecticide is a pesticide whose purpose is to kill or to prevent the multiplication of insects. ...
Malathion is a organophosphate parasympathomimetic which binds irreversibly to cholinesterase. ...
A herbicide is a pesticide used to kill unwanted plants. ...
Glyphosate (N-(phosphonomethyl) glycine, C3H8NO5P) is a non-selective herbicide to kill weeds, especially perennials. ...
Disinfection is the destruction of pathogenic and other kinds of microorganisms by physical or chemical means. ...
Triclosan (chemically 5-chloro-2-(2,4-dichlorophenoxy)phenol) is a potent wide spectrum antibacterial and antifungal agent. ...
The structure of sildenafil (Viagra). |
The coenzyme folic acid (left) compared to the anti-cancer drug methotrexate (right). |
The structure of a complex between penicillin G and the Streptomyces transpeptidase. Generated from PDB 1PWC. | Image File history File links Sildenafil. ...
Image File history File links Sildenafil. ...
Image File history File links Methotrexate_and_folic_acid_compared. ...
Image File history File links Methotrexate_and_folic_acid_compared. ...
Image File history File links Download high-resolution version (742x633, 83 KB) I am author, Image of penicilloyl acyl enzyme complex of the Streptomyces R61 DD-peptidase with penicillin G. Generated from PDB 1PWC I, the creator of this work, hereby release it into the public domain. ...
Image File history File links Download high-resolution version (742x633, 83 KB) I am author, Image of penicilloyl acyl enzyme complex of the Streptomyces R61 DD-peptidase with penicillin G. Generated from PDB 1PWC I, the creator of this work, hereby release it into the public domain. ...
Chemotherapy The most common uses for enzyme inhibitors are as drugs to treat disease. Many of these inhibitors target a human enzyme and aim to correct a pathological condition. However, not all drugs are enzyme inhibitors. Some, such as anti-epileptic drugs, alter enzyme activity by causing more or less of the enzyme to be produced. These effects are called enzyme induction and inhibition and are alterations in gene expression, which is unrelated to the type of enzyme inhibition discussed here. Other drugs interact with cellular targets that are not enzymes, such as ion channels or membrane receptors. The anticonvulsants, sometimes also called antiepileptics, belong to a diverse group of pharmaceuticals used in prevention of the occurrence of epileptic seizures. ...
Enzyme induction is a process in which a molecule ( a drug) induces ( initiates or enhances) the expression of an enzyme. ...
Gene expression, or simply expression, is the process by which a genes DNA sequence is converted into the structures and functions of a cell. ...
Ion channels are pore-forming proteins that help to establish and control the small voltage gradient that exists across the plasma membrane of all living cells (see cell potential) by allowing the flow of ions down their electrochemical gradient. ...
In biochemistry, a receptor is a protein on the cell membrane or within the cytoplasm or cell nucleus that binds to a specific molecule (a ligand), such as a neurotransmitter, hormone, or other substance, and initiates the cellular response to the ligand. ...
An interesting example of a medicinal enzyme inhibitor is sildenafil (Viagra), a common treatment for male erectile dysfunction, (figure, right). This compound is a potent inhibitor of cGMP specific phosphodiesterase type 5, the enzyme that degrades the signalling molecule cyclic guanosine monophosphate.[23] This signalling molecule triggers smooth muscle relaxation and allows blood flow into the corpus cavernosum, which causes an erection. Since the drug decreases the activity of the enzyme that halts the signal, it makes this signal last for a longer period of time. Sildenafil citrate, sold under the names Viagra, Revatio and generically under various other names, is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. ...
cGMP specific phosphodiesterase type 5 is an enzyme (EC 3. ...
Cyclic guanosine monophosphate (cGMP) is a second messenger derived from GTP. Cyclic guanosine monophosphate (cGMP) is a cyclic nucleotide derived from guanosine triphosphate (GTP). ...
A corpus cavernosum is one of a pair of a sponge-like regions of erectile tissue which contain most of the blood in the male penis during erection. ...
Another example of the structural similarity of some inhibitors to the substrates of the enzymes they target is seen in the figure comparing the drug methotrexate to folic acid. Folic acid is the oxidised form of the substrate of dihydrofolate reductase, an enzyme that is potently inhibited by methotrexate. Methotrexate blocks the action of dihydrofolate reductase and thereby halts thymidine biosynthesis. This block of nucleotide biosynthesis is selectively toxic to rapidly growing cells, therefore methotrexate is often used in cancer chemotherapy.[24] Methotrexate (rINN) (IPA: ), abbreviated MTX and formerly known as amethopterin, is an antimetabolite drug used in treatment of cancer and autoimmune diseases. ...
Folic acid and folate (the anion form) are forms of a water-soluble B vitamin. ...
Categories: Biochemistry stubs | EC 1. ...
The chemical structure of deoxythymidine Thymidine (more precisely called deoxythymidine can also be labelled deoxyribosylthymine, and thymine deoxyriboside) is a chemical compound, more precisely a pyrimidine deoxynucleoside. ...
A nucleotide is a chemical compound that consists of a heterocyclic base, a sugar, and one or more phosphate groups. ...
Drugs also are used to inhibit enzymes needed for the survival of pathogens. For example, bacteria are surrounded by a thick cell wall made of a net-like polymer called peptidoglycan. Many antibiotics such as penicillin and vancomycin inhibit the enzymes that produce and then cross-link the strands of this polymer together.[25] This causes the cell wall to lose strength and the bacteria to burst. In the figure, a molecule of penicillin (shown in a ball-and stick form) is shown bound to its target, the transpeptidase from the bacteria Streptomyces R61 (the protein is shown as a ribbon-diagram). A pathogen (literally birth of pain from the Greek παθογένεια) is a biological agent that can cause disease to its host. ...
Bacteria, despite their apparent simplicity contain a well developed cell structure which is resonsible for many of their unique biological properties. ...
Peptidoglycan, also known as murein, is a substance that forms a homogeneous layer lying outside the plasma membrane in bacteria. ...
Penicillin nucleus Penicillin (sometimes abbreviated PCN) refers to a group of β-lactam antibiotics used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms. ...
Vancomycin (INN) (IPA: ) is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. ...
The bacterial enzyme which cross links the peptidoglycan chains to form rigid cell walls. ...
Proteins are amino acid chains, made up from 20 different L-α-amino acids, also referred to as residues, that fold into unique three-dimensional protein structures. ...
Drug design is facilitated when an enzyme that is essential to the pathogen's survival is absent or very different in humans. In the example above, humans do not make peptidoglycan, therefore inhibitors of this process are selectively toxic to bacteria. Selective toxicity is also produced in antibiotics by exploiting differences in the structure of the ribosomes in bacteria, or how they make fatty acids. Drug design is the approach of finding drugs by design, based on their biological targets. ...
Figure 1: Ribosome structure indicating small subunit (A) and large subunit (B). ...
In chemistry, especially biochemistry, a fatty acid is a carboxylic acid (or organic acid), often with a long aliphatic tail (long chains), either saturated or unsaturated. ...
Metabolic control Enzyme inhibitors are also important in metabolic control. Many metabolic pathways in the cell are inhibited by metabolites that control enzyme activity through allosteric regulation or substrate inhibition. A good example is the allosteric regulation of the glycolytic pathway. This catabolic pathway consumes glucose and produces ATP, NADH and pyruvate. A key step for the regulation of glycolysis is an early reaction in the pathway catalysed by phosphofructokinase-1 (PFK1). When ATP levels rise, ATP binds an allosteric site in PFK1 to decrease the rate of the enzyme reaction; glycolysis is inhibited and ATP production falls. This negative feedback control helps maintain a steady concentration of ATP in the cell. However, metabolic pathways are not just regulated through inhibition since enzyme activation is equally important. With respect to PFK1, fructose 2,6-bisphosphate and ADP are examples of metabolites that are allosteric activators.[26] In biochemistry, a metabolic pathway is a series of chemical reactions occurring within a cell, catalyzed by enzymes, and resulting in either the formation of a metabolic product to be used or stored by the cell (metabolic sink), or the initiation of another metabolic pathway (then called a flux generating...
A metabolite is the product of metabolism. ...
In biochemistry, allosteric regulation is the regulation of an enzyme or protein by binding an effector molecule at the proteins allosteric site (that is, a site other than the proteins active site). ...
Glycolysis is a metabolic pathway by which a 6-carbon glucose (Glc) molecule is oxidized to two molecules of pyruvic acid (Pyr). ...
Anabolism is the aspect of metabolism that contributes to growth. ...
Glucose (Glc), a monosaccharide (or simple sugar), is the most important carbohydrate in biology. ...
Adenosine 5-triphosphate (ATP), discovered in 1929 by Karl Lohmann,[1] is a multifunctional nucleotide primarily known in biochemistry as the molecular currency of intracellular energy transfer. ...
Nicotinamide adenine dinucleotide (NAD+) Nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) are two important coenzymes found in cells. ...
Pyruvate (CH3COCOOâ) is the ionized form of pyruvic acid. ...
Phosphofructokinase (PFK) is the most important regulatory enzyme (EC 2. ...
It has been suggested that this article or section be merged with Feedback loop. ...
Adenosine diphosphate, abbreviated ADP, is a nucleotide. ...
Physiological enzyme inhibition can also be produced by specific protein inhibitors. This mechanism occurs in the pancreas, which synthesises many digestive precursor enzymes known as zymogens. Many of these are activated by the trypsin protease so it is important to inhibit the activity of trypsin in the pancreas to prevent the organ from digesting itself. One way in which the activity of trypsin is controlled is the production of a specific and potent trypsin inhibitor protein in the pancreas. This inhibitor binds tightly to trypsin, preventing the trypsin activity that would otherwise be detrimental to the organ.[27] Although the trypsin inhibitor is a protein, it avoids being hydrolysed as a substrate by the protease by excluding water from trypsin's active site and destabilising the transition state.[28] Other examples of physiological enzyme inhibitor proteins include the barstar inhibitor of the bacterial ribonuclease barnase[29] and the inhibitors of protein phosphatases.[30] For the song by Weird Al Yankovic, see Pancreas (song) The pancreas is an organ in the digestive and endocrine system that serves two major functions: exocrine (producing pancreatic juice containing digestive enzymes) and endocrine (producing several important hormones, including insulin). ...
A zymogen is an inactive enzyme pre-cursor. ...
Trypsin (EC 3. ...
Trypsin inhibitors are chemicals that reduce the bio-availability of trypsin, an amino acid essential to nutrition of many animals, including humans. ...
Barstar is a small protein synthesized by the bacterium Bacillus amyloliquefaciens. ...
Barnase is a bacterial protein that consists of 110 amino acids and has ribonuclease activity. ...
Protein phosphatases are enzymes that remove phosphate groups that have been attached to amino acid residues of proteins by protein kinases. ...
Natural poisons Animals and plants have evolved to synthesise a vast array of poisonous products including secondary metabolites, peptides and proteins that can act as inhibitors. Natural toxins are usually small organic molecules and are so diverse that there are probably natural inhibitors for most metabolic processes.[31] The metabolic processes targeted by natural poisons encompass more than enzymes in metabolic pathways and can also include the inhibition of receptor, channel and structural protein functions in a cell. For example, paclitaxel (taxol), an organic molecule found in the Pacific yew tree, binds tightly to tubulin dimers and inhibits their assembly into microtubules in the cytoskeleton.[32] Image File history File linksMetadata Download high-resolution version (3840x2160, 4114 KB) Description: red, green and puy lentils Image from commons link Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1. ...
Image File history File linksMetadata Download high-resolution version (3840x2160, 4114 KB) Description: red, green and puy lentils Image from commons link Permission is granted to copy, distribute and/or modify this document under the terms of the GNU Free Documentation License, Version 1. ...
Seed predation includes any process inflicted on a plantâs seeds by an animal that results in the inviability of the seed. ...
Trypsin inhibitors are chemicals that reduce the bio-availability of trypsin, an amino acid essential to nutrition of many animals, including humans. ...
Secondary metabolites are those chemical compounds in organisms that are not directly involved in the normal growth, development or reproduction of organisms. ...
Paclitaxel (Taxol®) is a drug used in the treatment of cancer. ...
Species Taxus baccata - European Yew Taxus brevifolia - Pacific (or Western) Yew Taxus canadensis - Canadian Yew Taxus chinensis - Chinese Yew Taxus cuspidata - Japanese Yew Taxus floridana - Florida Yew Taxus globosa - Mexican Yew Taxus sumatrana - Sumatran Yew Taxus wallichiana - Himalayan Yew Taxus is a genus of yews, small coniferous trees or shrubs...
Tubulin is the protein which makes up microtubules. ...
Microtubules are protein structures found within cells. ...
Many natural poisons act as neurotoxins that can cause paralysis leading to death and have functions for defence against predators or in hunting and capturing prey. Some of these natural inhibitors, despite their toxic attributes, are valuable for therapeutic uses at lower doses.[33] An example of a neurotoxin are the glycoalkaloids, from the plant species in the Solanaceae family (includes potato, tomato and aubergine), that are acetylcholinesterase inhibitors. Inhibition of this enzyme causes an uncontrolled increase in the acetylcholine neurotransmitter, muscular paralysis and then death. Neurotoxicity can also result from the inhibition of receptors; for example, atropine from deadly nightshade (Atropa belladonna) that functions as a competitive antagonist of the muscarinic acetylcholine receptors.[34] It has been suggested that Neurotoxicity be merged into this article or section. ...
Glycoalkaloid is a type of poisen found in spieces in the Nightshade family. ...
Genera Acnistus Atropa (deadly nightshade) Brugmansia (angels trumpet) Calibrachoa Capsicum (chile peppers) Cestrum Chamaesaracha Combera Crenidium Cuatresia Cyphanthera Cyphomandra Datura (jimsonweed) Hyoscyamus (henbane) Iochroma Lycium (boxthorn) Mandragora (mandrake) Nicandra Nicotiana (tobacco) Nolana Petunia Physalis (tomatillo) Scopolia Solandra Solanum (tomato, potato, eggplant) Streptosolen Wikispecies has information related to: Solanaceae The...
Binomial name Solanum tuberosum L. The potato (Solanum tuberosum) is a perennial plant of the Solanaceae, or nightshade, family, commonly grown for its starchy tuber. ...
Look up Tomato in Wiktionary, the free dictionary. ...
Binomial name Solanum melongena L. The aubergine, eggplant, or brinjal (Solanum melongena) is a solanaceous plant bearing a fruit of the same name, commonly used as a vegetable in cooking. ...
Acetylcholinesterase In biochemistry, cholinesterase is a term which refers to one of the two enzymes: Acetylcholinesterase (EC 3. ...
Atropine is a tropane alkaloid extracted from the deadly nightshade (Atropa belladonna) and other plants of the family Solanaceae. ...
For information on the erotic actress Belladonna see: Belladonna. ...
A competitive antagonist is a receptor antagonist which binds to a receptor but fails to activate it. ...
An acetylcholine receptor (abbreviated AChR) is an integral membrane protein that responds to the binding of the neurotransmitter acetylcholine. ...
Although many natural toxins are secondary metabolites, these poisons also include peptides and proteins. An example of a toxic peptide is alpha-amanitin, which is found in relatives of the death cap mushroom. This is a potent enzyme inhibitor, in this case preventing the RNA polymerase II enzyme from transcribing DNA.[35] The algal toxin microcystin is also a peptide and is an inhibitor of protein phosphatases.[36] This toxin can contaminate water supplies after algal blooms and is a known carcinogen that can also cause acute liver hemorrhage and death at higher doses.[37] Alpha-amanitin or α-amanitin is a cyclic nonribosomal peptide of eight amino acids. ...
Binomial name Amanita phalloides (Vaill. ...
RNA polymerase II (also called RNAP II and Pol II) transcribes DNA to synthesize precursors of mRNA and most snRNA. A 550 kDa complex of 12 subunits, RNAP II is the most studied type of RNA polymerase. ...
Chemical structure of Microcystin LR Microcystins are cyclic nonribosomal peptides produced by cyanobacteria. ...
Protein phosphatases are enzymes that remove phosphate groups that have been attached to amino acid residues of proteins by protein kinases. ...
An algal bloom is a relatively rapid increase in the population of (usually) phytoplankton algae in an aquatic system. ...
Proteins can also be natural poisons, such as the trypsin inhibitors (discussed above) that are found in some legumes, as shown in the figure above. A less common class of toxins are toxic enzymes: these act as irreversible inhibitors of their target enzymes and work by chemically modifying their substrate enzymes. An example is ricin, an extremely potent protein toxin found in castor oil beans. This enzyme is a glycosidase that inactivates ribosomes. Since ricin is a catalytic irreversible inhibitor, this allows just a single molecule of ricin to kill a cell.[38] Trypsin inhibitors are chemicals that reduce the bio-availability of trypsin, an amino acid essential to nutrition of many animals, including humans. ...
Pulses are defined by the Food and Agricultural Organization of the United Nations (FAO) as annual leguminous crops yielding from one to twelve grains or seeds of variable size, shape and color within a pod. ...
Castor beans The protein ricin (pronounced ) is a toxin from the castor bean (Ricinus communis). ...
See also In biochemistry, allosteric regulation is the regulation of an enzyme or protein by binding an effector molecule at the proteins allosteric site (that is, a site other than the proteins active site). ...
Enzyme assays are laboratory methods for measuring enzymatic activity. ...
Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacy involved with designing, synthesizing and developing pharmaceutical drugs. ...
A pharmacophore is a three-dimensional substructure of a molecule that carries (phoros) the essential features responsible for a drugs (pharmacon) biological activity. ...
References - ^ Shapiro R, Vallee BL. Interaction of human placental ribonuclease with placental ribonuclease inhibitor. Biochemistry. 1991 Feb 26;30(8):2246–55. PMID 1998683
- ^ Berg J., Tymoczko J. and Stryer L. (2002) Biochemistry. W. H. Freeman and Company ISBN 0-7167-4955-6
- ^ *Irwin H. Segel, Enzyme Kinetics : Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. Wiley–Interscience; New edition (1993), ISBN 0-471-30309-7
- ^ Holdgate GA. Making cool drugs hot: isothermal titration calorimetry as a tool to study binding energetics. Biotechniques. 2001 Jul;31(1):164–6 PMID 11464510
- ^ Leatherbarrow RJ. Using linear and non-linear regression to fit biochemical data. Trends Biochem Sci. 1990 Dec;15(12):455–8. PMID 2077683
- ^ Tseng SJ, Hsu JP. A comparison of the parameter estimating procedures for the Michaelis–Menten model. J Theor Biol. 1990 Aug 23;145(4):457–64. PMID 2246896
- ^ a b Irwin H. Segel, Enzyme Kinetics : Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems. Wiley-Interscience; New Ed edition (1993), ISBN 0-471-30309-7
- ^ Dixon, M. Webb, E.C., Thorne, C.J.R. and Tipton K.F., Enzymes (3rd edition) Longman, London (1979) See p. 126
- ^ Hsu JT, Wang HC, Chen GW, Shih SR. Antiviral drug discovery targeting to viral proteases. Curr Pharm Des. 2006; 12(11):1301–14. PMID 16611117
- ^ Bogoyevitch MA, Barr RK, Ketterman AJ. Peptide inhibitors of protein kinases—discovery, characterisation and use. Biochim Biophys Acta. 2005 Dec 30;1754(1-2):79–99. PMID 16182621
- ^ Lundblad R. L. Chemical Reagents for Protein Modification CRC Press Inc (2004) ISBN 0-84-931983-8
- ^ N. Price, B. Hames, D. Rickwood (Ed.) Proteins LabFax Academic Press (1996) ISBN 0-12-564710-7
- ^ Maurer T, Fung HL. Comparison of Methods for Analyzing Kinetic Data From Mechanism-Based Enzyme Inactivation: Application to Nitric Oxide Synthase. AAPS PharmSci. (2000) 2(1)E8. PMID 11741224
- ^ a b Poulin R, Lu L, Ackermann B, Bey P, Pegg AE. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J Biol Chem. 1992 Jan 5;267(1):150–8. PMID 1730582
- ^ Szedlacsek, S.E. and Duggleby, R.G. Kinetics of slow and tight-binding inhibitors. Meth. Enzymol., (1995) 249: 144–180. PMID 7791610
- ^ Stone SR, Morrison JF. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of foliate analogues. Biochim Biophys Acta. 1986 Feb 14;869(3):275–85. PMID 3511964
- ^ Hille R, Massey V. Tight binding inhibitors of xanthine oxidase. Pharmacol Ther. 1981;14(2):249–63. PMID 4322209
- ^ Reardon JE. Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition. J Biol Chem. 1989 Nov 15;264(32):19039–44. PMID 2553730
- ^ J. A. Cohen , R. A. Oosterbaan and F. Berends Organophosphorus compounds Meth. Enzymol. (1967) 11, 686
- ^ Brenner, G. M. (2000): Pharmacology. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7216-7757-6
- ^ Saravanamuthu A, Vickers TJ, Bond CS, Peterson MR, Hunter WN, Fairlamb AH. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. J Biol Chem. 2004 Jul 9;279(28):29493–500. PMID 15102853
- ^ Hunter WN. Rational drug design: a multidisciplinary approach. Mol Med Today. 1995 Apr;1(1):31, 34. PMID 9415135
- ^ Maggi M, Filippi S, Ledda F, Magini A, Forti G. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. Eur J Endocrinol. 2000 Aug;143(2):143–54 PMID 10913932
- ^ McGuire JJ. Anticancer antifolates: current status and future directions. Curr Pharm Des. 2003;9(31):2593–613. PMID 14529544
- ^ Katz AH, Caufield CE. Structure-based design approaches to cell wall biosynthesis inhibitors. Curr Pharm Des. 2003;9(11):857–66. PMID 12678870
- ^ Okar DA, Lange AJ. Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes. Biofactors. 1999;10(1):1–14.
- ^ Nicholas Price, Lewis Stevens, Fundamentals of Enzymology, Oxford University Press, (1999) ISBN 0-19-850229-X
- ^ Smyth TP. Substrate variants versus transition state analogues as noncovalent reversible enzyme inhibitors. Bioorg Med Chem. 2004 Aug 1;12(15):4081–8. PMID 15246086
- ^ Hartley RW. Barnase and barstar: two small proteins to fold and fit together. Trends Biochem Sci. 1989 Nov;14(11):450–4. PMID 2696173
- ^ Oliver CJ, Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front Biosci. 1998 Sep 1;3:D961–72. PMID 9727084
- ^ Tan G, Gyllenhaal C, Soejarto DD. Biodiversity as a source of anticancer drugs. Curr Drug Targets. 2006 Mar;7(3):265-77. PMID 16515527
- ^ Abal M, Andreu JM, Barasoain I. Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. Curr Cancer Drug Targets. 2003 Jun;3(3):193–203. PMID 12769688
- ^ Hostettmann K, Borloz A, Urbain A, Marston A, Natural Product Inhibitors of Acetylcholinesterase Current Organic Chemistry, 2006 May;10(8):825-47
- ^ DeFrates LJ, Hoehns JD, Sakornbut EL, Glascock DG, Tew AR. Antimuscarinic intoxication resulting from the ingestion of moonflower seeds. Ann Pharmacother. 2005 Jan;39(1):173-6. PMID 15572604
- ^ Vetter J. Toxins of Amanita phalloides. Toxicon. 1998 Jan;36(1):13–24. PMID 9604278
- ^ Holmes CF, Maynes JT, Perreault KR, Dawson JF, James MN. Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins. Curr Med Chem. 2002 Nov;9(22):1981-9. PMID 12369866
- ^ Bischoff K. The toxicology of microcystin-LR: occurrence, toxicokinetics, toxicodynamics, diagnosis and treatment. Vet Hum Toxicol. 2001 Oct;43(5):294-7. PMID 11577938
- ^ Hartley MR, Lord JM. Cytotoxic ribosome-inactivating lectins from plants. Biochim Biophys Acta. 2004 Sep 1;1701(1-2):1–14. PMID 15450171
External links - Web tutorial on enzyme inhibition, Tutorial by Dr Peter Birch of the University of Paisley, containing very clear animations.
- Symbolism and Terminology in Enzyme Kinetics, Recommendations of the Nomenclature Committee of the International Union of Biochemistry (NC-IUB) on enzyme inhibition terminology.
- PubChem from NCBI, Database of drugs and enzyme inhibitors.
- BRENDA, Database of enzymes giving lists of known inhibitors for each entry.
- Enzymes, Kinetics and Diagnostic Use, On-line lecture concentrating on medical applications of enzyme inhibitors: by Dr. Michael W. King of the IU School of Medicine.
Purge this page's server cache
| Topics in Medicinal Chemistry | | ADME | Bioavailability | Chemogenomics | Drug Design | Drug Discovery | Enzyme Inhibition | Mechanism of Action | New Chemical Entity | Pharmacodynamics | Pharmacokinetics | Pharmacology | Pharmacophore | Quantitative Structure-Activity Relationship In Chemistry:A chemical inhibitor is any substance which will prevent any two other substances from reacting due to its presence, often by reacting with one or the other first. ...
Uncompetitive inhibition takes place when an enzyme inhibitor binds only to the complex formed between the enzyme and the substrate (the E-S complex). ...
Non-competitive inhibition is a type of inhibition that reduces the maximum rate of a chemical reaction (Vmax) without changing the apparent binding affinity of the enzyme for the substrate (Km). ...
Suicide inhibition, also known as suicide inactivation and mechanism-based inactivation, is a form of irreversible enzyme inhibition that occurs when an enzyme binds a substrate analogue and forms a complex with it during the normal catalysis reaction. ...
Mixed inhibition refers to a combination of two different types of reversible enzyme inhibition--competitive inhibition and uncompetitive inhibition. ...
Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacy involved with designing, synthesizing and developing pharmaceutical drugs. ...
ADME is an acronym in pharmacokinetics and pharmacology for Absorption, Distribution, Metabolism, and Excretion, and describes the disposition of a pharmaceutical compound within an organism. ...
In pharmacology, bioavailability is used to describe the fraction of an administered dose of medication that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. ...
Chemogenomics can be defined as a genomic response to chemical compounds. ...
Drug design is the approach of finding drugs by design, based on their biological targets. ...
In medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are discovered and/or designed. ...
Wikipedia does not yet have an article with this exact name. ...
According to the U.S. Food and Drug Administration, a new chemical entity means a drug that contains no active moiety that has been approved by FDA in any other application submitted under section 505(b) of the Food, Drug and Cosmetic Act. ...
Pharmacodynamics is the study of the biochemical and physiological effects of drugs and the mechanisms of drug action and the relationship between drug concentration and effect. ...
Pharmacokinetics is a branch of pharmacology dedicated to the study of the time course of substances and their relationship with an organism or system. ...
Pharmacology (in Greek: pharmacon (ÏάÏμακον) meaning drug, and logos (λÏγοÏ) meaning science) is the study of how substances interact with living organisms to produce a change in function. ...
A pharmacophore is a three-dimensional substructure of a molecule that carries (phoros) the essential features responsible for a drugs (pharmacon) biological activity. ...
Quantitative structure-activity relationship (QSAR) is the process by which chemical structure is quantitatively correlated with a well defined process, such as biological activity or chemical reactivity. ...
| |